# A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

> **NCT07489482** · PHASE1 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** SHR-3167 Injection

## Key facts

- **NCT ID:** NCT07489482
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07489482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07489482, "A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07489482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*